DrugRepV Browse Page

DrugRepV browse page allows user to take a glance of the particular antiviral agent.Fields in the webpage is hylerlinked ot various external repositories like DrugBank, PubChem, Clinicaltrials.gov,and PubMed.User can explore the biological, Clinical, Chemical, and Structural details of every repurposed drug candidate.By clicking on the table header arrows, user can sort entries in ascending or descending order.


Total number of Records for Modelling based approach are 3

DrugRepV_ID	Antiviral Name	Drug type	Primary Indication	Secondary Indication	Strain	Pathways	Assay	Activity	Clinical Status	References
DrugRepV_6491	Lamivudine	Antiinfectives For Systemic Use	Acquired immunodeficiency syndrome | Hepatitis B virus	Human immunodeficiency virus	NA		Modelling based approach	Decrease (50 %)	Approved	26796142
DrugRepV_6492	Emtricitabine	Antiinfectives For Systemic Use	Acquired immunodeficiency syndrome	Human immunodeficiency virus	NA		Modelling based approach	Decrease (50 %)	Approved	26796142
DrugRepV_6493	Tenofovir disoproxil Fumarate	Antiinfectives For Systemic Use	Acquired immunodeficiency syndrome	Human immunodeficiency virus	NA		Modelling based approach	Decrease (50 %)	NA	26796142